Abstract
Short summary The value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for TN-staging in Head & neck cancer (HNC) has been proven in numerous studies. A few studies have investigated the value of 18F-FDG PET/MRI in staging of HNC and the combined results indicate a potential for PET/MRI but the scientific evidence remains weak.